tradingkey.logo

Cigna Group

CI
277.150USD
+2.450+0.89%
Close 12/15, 16:00ETQuotes delayed by 15 min
73.89BMarket Cap
12.17P/E TTM

Cigna Group

277.150
+2.450+0.89%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Cigna Group

Currency: USD Updated: 2025-12-15

Key Insights

Cigna Group's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 3/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 329.04.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cigna Group's Score

Industry at a Glance

Industry Ranking
3 / 78
Overall Ranking
39 / 4589
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 26 analysts
Buy
Current Rating
329.044
Target Price
+24.86%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cigna Group Highlights

StrengthsRisks
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 247.12B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.90% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.
Undervalued
The company’s latest PE is 12.17, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 242.25M shares, increasing 0.07% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 90.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-15

The current financial score of Cigna Group is 8.51, ranking 21/78 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 69.75B, representing a year-over-year increase of 9.50%, while its net profit experienced a year-over-year increase of 152.77%.

Score

Industry at a Glance

Previous score
8.51
Change
0

Financials

5.41

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.86

Operational Efficiency

8.68

Growth Potential

10.00

Shareholder Returns

9.61

Cigna Group's Company Valuation

Currency: USD Updated: 2025-12-15

The current valuation score of Cigna Group is 8.47, ranking 10/78 in the Healthcare Providers & Services industry. Its current P/E ratio is 12.17, which is 176.12% below the recent high of 33.61 and 10.13% above the recent low of 10.94.

Score

Industry at a Glance

Previous score
8.47
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 3/78
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-15

The current earnings forecast score of Cigna Group is 8.15, ranking 25/78 in the Healthcare Providers & Services industry. The average price target for Cigna Group is 325.00, with a high of 378.00 and a low of 270.00.

Score

Industry at a Glance

Previous score
8.15
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 26 analysts
Buy
Current Rating
329.044
Target Price
+24.86%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

9
Total
22
Median
19
Average
Company name
Ratings
Analysts
Cigna Group
CI
26
Unitedhealth Group Inc
UNH
29
Humana Inc
HUM
28
Elevance Health Inc
ELV
24
Centene Corp
CNC
22
Molina Healthcare Inc
MOH
20
1
2

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-15

The current price momentum score of Cigna Group is 9.02, ranking 24/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 286.01 and the support level at 263.28, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.84
Change
0.18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
2.264
Neutral
RSI(14)
54.501
Neutral
STOCH(KDJ)(9,3,3)
79.761
Buy
ATR(14)
5.541
Low Volatility
CCI(14)
68.874
Neutral
Williams %R
15.412
Overbought
TRIX(12,20)
-0.112
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
269.884
Buy
MA10
269.124
Buy
MA20
271.687
Buy
MA50
280.367
Sell
MA100
286.344
Sell
MA200
302.617
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-15

The current institutional shareholding score of Cigna Group is 10.00, ranking 1/78 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 91.45%, representing a quarter-over-quarter decrease of 0.49%. The largest institutional shareholder is The Vanguard, holding a total of 25.62M shares, representing 9.59% of shares outstanding, with 1.53% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
25.60M
-1.65%
BlackRock Institutional Trust Company, N.A.
12.41M
-6.42%
State Street Investment Management (US)
12.26M
-1.68%
T. Rowe Price Associates, Inc.
Star Investors
9.90M
-15.05%
MFS Investment Management
11.41M
+0.92%
8.95M
+0.68%
Fidelity Management & Research Company LLC
8.81M
-16.31%
Sanders Capital, LLC
7.79M
-2.46%
GQG Partners, LLC
5.77M
+18.07%
Geode Capital Management, L.L.C.
5.96M
-1.22%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-15

The current risk assessment score of Cigna Group is 6.82, ranking 25/78 in the Healthcare Providers & Services industry. The company's beta value is 0.27. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
6.82
Change
0
Beta vs S&P 500 index
0.27
VaR
+2.53%
240-Day Maximum Drawdown
+28.12%
240-Day Volatility
+33.08%

Return

Best Daily Return
60 days
+5.81%
120 days
+5.81%
5 years
+16.68%
Worst Daily Return
60 days
-17.39%
120 days
-17.39%
5 years
-17.39%
Sharpe Ratio
60 days
-0.27
120 days
-0.49
5 years
+0.33

Risk Assessment

Maximum Drawdown
240 days
+28.12%
3 years
+33.38%
5 years
+33.38%
Return-to-Drawdown Ratio
240 days
+0.03
3 years
-0.12
5 years
+0.10
Skewness
240 days
-2.71
3 years
-0.45
5 years
-0.61

Volatility

Realised Volatility
240 days
+33.08%
5 years
+28.36%
Standardised True Range
240 days
+2.82%
5 years
+2.36%
Downside Risk-Adjusted Return
120 days
-49.15%
240 days
-49.15%
Maximum Daily Upside Volatility
60 days
+31.47%
Maximum Daily Downside Volatility
60 days
+38.02%

Liquidity

Average Turnover Rate
60 days
+0.70%
120 days
+0.68%
5 years
--
Turnover Deviation
20 days
+6.28%
60 days
+12.99%
120 days
+8.82%

Peer Comparison

Healthcare Providers & Services
Cigna Group
Cigna Group
CI
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
Alignment Healthcare Inc
ALHC
8.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
Lifestance Health Group Inc
LFST
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
Option Care Health Inc
OPCH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
Natera Inc
NTRA
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Addus Homecare Corp
Addus Homecare Corp
ADUS
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Cigna Group?

The TradingKey Stock Score provides a comprehensive assessment of Cigna Group based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Cigna Group’s performance and outlook.

How do we generate the financial health score of Cigna Group?

To generate the financial health score of Cigna Group, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Cigna Group's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Cigna Group.

How do we generate the company valuation score of Cigna Group?

To generate the company valuation score of Cigna Group, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Cigna Group’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Cigna Group’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Cigna Group.

How do we generate the earnings forecast score of Cigna Group?

To calculate the earnings forecast score of Cigna Group, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Cigna Group’s future.

How do we generate the price momentum score of Cigna Group?

When generating the price momentum score for Cigna Group, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Cigna Group’s prices. A higher score indicates a more stable short-term price trend for Cigna Group.

How do we generate the institutional confidence score of Cigna Group?

To generate the institutional confidence score of Cigna Group, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Cigna Group’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Cigna Group.

How do we generate the risk management score of Cigna Group?

To assess the risk management score of Cigna Group, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Cigna Group’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Cigna Group.
KeyAI